Literature DB >> 16325069

Leg ulcers: uncommon presentations.

Finn Gottrup1, Tonny Karlsmark.   

Abstract

Uncommon presentations like vasculitis or other immunologic causes and malignancy account for about 1% to 2% of patients suffering from leg ulcers. We focus on such uncommon leg ulcers including: cutaneous vasculitis causing cutaneous ulceration, other immunologic or metabolic cutaneous lesions such as pyoderma gangrenosum and necrobiosis lipoidica, and ulcers based on neoplastic etiology. A short description on leg ulcers in the tropics is also included. The described uncommon presentations of leg ulcers are typically difficult to diagnose and treat; it is a specialist's job to take care of patients with these types of ulcers. Multidisciplinary specialized wound healing concepts integrated in the national health care system, as an accepted expert function, is the ideal way to organize the wound healing area. Such a system would result in an earlier diagnosis and more sufficient treatment for patients with uncommon presentations of leg ulcers.

Entities:  

Mesh:

Year:  2005        PMID: 16325069     DOI: 10.1016/j.clindermatol.2005.01.018

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  6 in total

1.  Topical morphine gel in the treatment of painful leg ulcers, a double-blind, placebo-controlled clinical trial: a pilot study.

Authors:  Salumeh Bastami; Thomas Frödin; Johan Ahlner; Srinivas Uppugunduri
Journal:  Int Wound J       Date:  2011-12-13       Impact factor: 3.315

2.  Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus.

Authors:  A Patsatsi; A Kyriakou; D Sotiriadis
Journal:  Case Rep Dermatol       Date:  2011-04-18

3.  Systemic therapy for leg ulcers.

Authors:  Vijay Langer
Journal:  Indian Dermatol Online J       Date:  2014-10

4.  Influence of ulceration etiology on the global quality of life and its specific dimensions, including the control of pain, in patients with lower limb vascular insufficiency.

Authors:  Justyna Cwajda-Białasik; Maria T Szewczyk; Paulina Mościcka; Arkadiusz Jawień; Robert Ślusarz
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

5.  Hyperkeratotic necrobiosis lipoidica.

Authors:  Farhan Khan; Marigdalia K Ramirez-Fort; C Stanley Chan; Theodore Rosen
Journal:  Dermatol Pract Concept       Date:  2013-01-31

6.  Necrobiosis Lipoidica Diabeticorum: A pediatric case report.

Authors:  Clara Bonura; Giulio Frontino; Andrea Rigamonti; Roseila Battaglino; Valeria Favalli; Giusy Ferro; Chiara Rubino; Paolo Del Barba; Filippo Pesapane; Gianluca Nazzaro; Raffaele Gianotti; Riccardo Bonfanti; Franco Meschi; Giuseppe Chiumello
Journal:  Dermatoendocrinol       Date:  2014-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.